Cargando…
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493218/ https://www.ncbi.nlm.nih.gov/pubmed/37691051 http://dx.doi.org/10.1038/s41392-023-01592-4 |
_version_ | 1785104426562748416 |
---|---|
author | Weiskirchen, Ralf |
author_facet | Weiskirchen, Ralf |
author_sort | Weiskirchen, Ralf |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10493218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104932182023-09-12 Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy Weiskirchen, Ralf Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2023-09-11 /pmc/articles/PMC10493218/ /pubmed/37691051 http://dx.doi.org/10.1038/s41392-023-01592-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Highlight Weiskirchen, Ralf Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title | Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title_full | Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title_fullStr | Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title_full_unstemmed | Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title_short | Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
title_sort | targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493218/ https://www.ncbi.nlm.nih.gov/pubmed/37691051 http://dx.doi.org/10.1038/s41392-023-01592-4 |
work_keys_str_mv | AT weiskirchenralf targetingcoppertocombatmacrophagedriveninflammationapotentialadvancedtherapeuticstrategy |